Silva Pharmaceuticals Limited (DSE:SILVAPHL)

Market Cap	1.35B
Revenue (ttm)	370.96M
Net Income (ttm)	-135.93M
Shares Out	136.50M
EPS (ttm)	-1.00
PE Ratio	n/a
Forward PE	n/a
Dividend	0.10 (1.02%)
Ex-Dividend Date	Dec 2, 2024

Volume	362,915
Average Volume	177,167
Open	9.90
Previous Close	9.80
Day's Range	9.80 - 10.20
52-Week Range	7.60 - 14.40
Beta	-0.05
RSI	57.13
Earnings Date	Jan 28, 2026

About Silva Pharmaceuticals

Silva Pharmaceuticals Limited engages in manufacturing and marketing of pharmaceuticals finished products in Bangladesh and internationally. The company offers drugs for various categories, including antibiotics, analgesics, anti-diabetics, narcotics, anti-pyretics, anti-inflammatory, anti ulcerants, antiemetic, gastroprokinetic, antihistamine, anti-spasmodic expectorants, and vitamins and mineral. It also provides pharmaceutical products in therapeutic areas, such as anemias and other blood disorders, central nervous system, gastro- intestinal...

• Industry: Pharmaceutical Preparations
• Founded: 2001
• Employees: 615
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: SILVAPHL

Financial Performance

In 2025, Silva Pharmaceuticals's revenue was 383.65 million, a decrease of -36.02% compared to the previous year's 599.66 million. Losses were -132.95 million, 106.2% more than in 2024.